X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
alzheimer's disease (10) 10
long-term potentiation (6) 6
neurology (6) 6
oligomers (6) 6
animals (5) 5
brain (5) 5
index medicus (5) 5
insulin (5) 5
alzheimer’s disease (4) 4
amyloid beta-peptides - toxicity (4) 4
animal models (4) 4
insulin resistance (4) 4
mice (4) 4
neurosciences (4) 4
alzheimer disease - metabolism (3) 3
cell biology (3) 3
diabetes (3) 3
female (3) 3
hippocampus (3) 3
inflammation (3) 3
intranasal insulin (3) 3
male (3) 3
mouse model (3) 3
neurons - drug effects (3) 3
rats (3) 3
signal transduction (3) 3
synaptic plasticity (3) 3
tau pathology (3) 3
a-beta (2) 2
adipokine (2) 2
adiponectin (2) 2
aged (2) 2
alzheimer disease - genetics (2) 2
alzheimer disease - pathology (2) 2
alzheimers disease (2) 2
amyloid-beta (2) 2
amyloid-beta oligomers (2) 2
amyloid-β oligomers (2) 2
analysis (2) 2
biochemistry & molecular biology (2) 2
brain - metabolism (2) 2
central-nervous-system (2) 2
cognitive ability (2) 2
cognitive control (2) 2
cognitive decline (2) 2
cognitive impairment (2) 2
diabetes mellitus (2) 2
disease models, animal (2) 2
endoplasmic-reticulum stress (2) 2
humans (2) 2
hypoglycemic agents - pharmacology (2) 2
impairment (2) 2
insulin receptor substrate proteins - metabolism (2) 2
leptin (2) 2
macaca fascicularis (2) 2
medicine, research & experimental (2) 2
memory (2) 2
memory disorders - metabolism (2) 2
memory impairment (2) 2
mice, inbred c57bl (2) 2
middle aged (2) 2
neurodegenerative diseases (2) 2
neurons - metabolism (2) 2
neuroprotection (2) 2
nonhuman primate (2) 2
obesity (2) 2
phosphorylation (2) 2
physiological aspects (2) 2
primates (2) 2
protein binding (2) 2
proteins (2) 2
rats, wistar (2) 2
research (2) 2
synapse loss (2) 2
type 2 diabetes (2) 2
unfolded protein response (2) 2
3xtg-ad mouse model (1) 1
a-beta oligomers (1) 1
abridged index medicus (1) 1
accelerated weight-loss (1) 1
activated protein-kinase (1) 1
activation (1) 1
adipose tissue (1) 1
adipose-tissue inflammation (1) 1
adolescent (1) 1
adult (1) 1
aged, 80 and over (1) 1
alzheimer disease - cerebrospinal fluid (1) 1
alzheimer disease - chemically induced (1) 1
alzheimer disease - physiopathology (1) 1
alzheimer disease - prevention & control (1) 1
alzheimer disease - psychology (1) 1
alzheimers-disease (1) 1
amyloid beta-peptides - administration & dosage (1) 1
amyloid beta-peptides - chemistry (1) 1
amyloid beta-protein (1) 1
amyloid fibril formation (1) 1
amyloid oligomers (1) 1
amyloidosis (1) 1
antibodies, monoclonal - pharmacology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


NATURE MEDICINE, ISSN 1078-8956, 01/2019, Volume 25, Issue 1, pp. 165 - 165
Journal Article
Cell Metabolism, ISSN 1550-4131, 12/2013, Volume 18, Issue 6, pp. 831 - 843
Journal Article
Cell Metabolism, ISSN 1550-4131, 12/2013, Volume 18, Issue 6, pp. 831 - 843
Alzheimer’s disease (AD) and type 2 diabetes appear to share similar pathogenic mechanisms. dsRNA-dependent protein kinase (PKR) underlies peripheral insulin... 
Journal Article
The Journal of Pathology, ISSN 0022-3417, 05/2018, Volume 245, Issue 1, pp. 85 - 100
Journal Article
Frontiers in Neuroscience, ISSN 1662-453X, 01/2019, Volume 12
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 04/2012, Volume 122, Issue 4, pp. 1339 - 1353
Defective brain insulin signaling has been suggested to contribute to the cognitive deficits in patients with Alzheimer's disease (AD). Although a connection... 
MAMMALIAN TARGET | MEDICINE, RESEARCH & EXPERIMENTAL | INTRANASAL INSULIN | RECEPTOR-DEPENDENT MECHANISM | AMYLOID-BETA | AXONAL-TRANSPORT | TNF-ALPHA | SYNAPTIC PLASTICITY | CULTURED HIPPOCAMPAL-NEURONS | PEPTIDE OLIGOMERS | TRANSGENIC MICE | Phosphorylation | Insulin - physiology | Humans | Middle Aged | Macaca fascicularis | Memory Disorders - metabolism | Male | Hippocampus - drug effects | Insulin Receptor Substrate Proteins - metabolism | Infliximab | Alzheimer Disease - prevention & control | Aged, 80 and over | Female | Neurons - metabolism | Neurons - drug effects | Alzheimer Disease - psychology | Hypoglycemic Agents - therapeutic use | Cells, Cultured - drug effects | Amyloid beta-Peptides - toxicity | Antibodies, Monoclonal - pharmacology | Mice, Inbred C57BL | Insulin Resistance | Rats | Mice, Transgenic | Hippocampus - pathology | Hippocampus - cytology | Maze Learning - drug effects | Hypoglycemic Agents - pharmacology | Peptides - pharmacology | Hippocampus - metabolism | Memory Disorders - prevention & control | Animals | MAP Kinase Signaling System - drug effects | Memory Disorders - etiology | Alzheimer Disease - metabolism | Venoms - therapeutic use | Aged | Cells, Cultured - metabolism | Mice | Protein Processing, Post-Translational | Venoms - pharmacology | Alzheimer Disease - genetics | Peptides - therapeutic use
Journal Article
Experimental Neurology, ISSN 0014-4886, 06/2019, Volume 316, pp. 1 - 11
Alzheimer’s disease (AD) is a devastating neurodegenerative disease affecting millions of people worldwide. AD is characterized by a profound impairment of... 
Insulin resistance | Animal models | Inflammation | Alzheimer’s disease | Insulin | Cognitive control
Journal Article